This compound is primarily used in research settings to study the role of geranylgeranyltransferase I (GGTase-I) in cellular processes. It acts as a selective inhibitor of GGTase-I, which is involved in the post-translational modification of proteins, particularly those related to cell signaling and proliferation. By inhibiting this enzyme, researchers can investigate its impact on cancer cell growth and survival, as GGTase-I is often implicated in the progression of certain types of cancers. Additionally, it is utilized to explore potential therapeutic strategies targeting pathways dependent on geranylgeranylation, offering insights into the development of novel treatments for diseases like cancer and other conditions involving abnormal cell signaling.